Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 EUR | -1.91% | +6.94% | -49.67% |
30/04 | Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
06/02 | Givaudan: agreement signed with Berkem | CF |
Chart calendar Groupe Berkem
Upcoming events on Groupe Berkem
Past events on Groupe Berkem
29/04/2024 | Q1 2024 Sales and Revenue Release |
29/04/2024 | Q4 2023 Earnings Release |
31/01/2024 | Q4 2023 Sales and Revenue Release |
24/10/2023 09:30 pm | Q2 2023 Earnings Release |
31/07/2023 | Q2 2023 Sales and Revenue Release - Revenue Release |
22/06/2023 07:30 pm | Annual General Meeting |
16/05/2023 11:00 pm | Q4 2022 Earnings Release |
27/04/2023 09:30 pm | Q1 2023 Sales and Revenue Release |
31/01/2023 10:30 pm | FY 2022 Sales and Revenue Release |
20/10/2022 | Q3 2022 Sales and Revenue Release |
29/09/2022 09:30 pm | Interim 2022 Earnings Release |
21/07/2022 09:30 pm | Interim 2022 Sales and Revenue Release |
03/06/2022 08:00 pm | Annual General Meeting |
19/04/2022 09:47 pm | FY 2021 Earnings Release |
26/01/2022 10:30 pm | FY 2021 Sales and Revenue Release |
Past dividends on Groupe Berkem
04/07/2022 | Annual 0.06 EUR |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 40,6 | 46,1 46,0 0.14% | 51,8 49,8 4.12% | 52,4 53,2 -1.5% |
EBITDA Million EUR | Released Forecast Spread | 0,00 | 9,20 9,00 2.22% | 7,89 8,13 -2.94% | 0,00 5,17 - |
EBIT Million EUR | Released Forecast Spread | 0,00 | 5,56 5,95 -6.55% | 3,61 4,33 -16.72% | 0,00 2,73 - |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 1,50 -1,00 249.7% | -1,40 3,35 -141.73% | 0,00 2,40 - |
Net income Million EUR | Released Forecast Spread | 1,44 | 0,53 0,70 -23.71% | -1,57 2,57 -161.06% | 0,00 2,23 - |
EPS EUR | Released Forecast Spread | 0,00 | 0,01 0,03 -66.67% | -0,09 0,15 -158.7% | 0,00 0,13 - |
Announcement Date | 10/11/21 | 19/04/22 | 16/05/23 | - |
Quarterly results
Fiscal Period | December | 2022 Q4 | 2023 S1 |
---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 12,5 10,3 21.36% | |
EBITDA Million EUR | Released Forecast Spread | 2,79 3,30 -15.33% | |
Announcement Date | 16/05/23 | - |
Past sector events for Groupe Berkem
03/05/2024 04:37 pm | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
03/05/2024 03:30 pm | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
03/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
03/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
03/05/2024 01:31 am | AMGEN INC.: Q1 2024 Earnings Release |
02/05/2024 11:13 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
02/05/2024 05:00 pm | ORGANON & CO.: Q1 2024 Earnings Release |
02/05/2024 04:30 pm | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
02/05/2024 11:00 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
02/05/2024 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALKEM Stock
- Calendar Groupe Berkem